.svg){kind=small}
Where to Buy
Zilla's is stocked at 38 licensed dispensaries across Michigan, with the deepest coverage in Grand Rapids, New Buffalo, Adrian, Flint, and Menominee. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Edible held 49.94% share in September 2026 but contracted sharply with a -42.13% year-over-year decline and a -16.11% month-over-month dip, while Topical reached 39.33% share on 129.99% YoY growth yet fell -51.40% MoM; Tincture & Sublingual, at 10.73% share, slid -23.54% YoY but jumped 58.29% MoM. Against a brand-level sales change of -14.85% YoY and a 24-month change of -20.34%, the mix indicates Edible is the largest drag and Topical is volatile despite high YoY growth, suggesting September 2026 demand consolidated into two swings — Edible deterioration and Topical retrenchment — while Tincture & Sublingual provided the only near-term offset.
With average price up 60.97% YoY to $21.60 and Edible averaging $15.81 versus Topical at $37.32, the shift raises effective price exposure toward higher-ticket Topical even as it lost -51.40% MoM share momentum, while Tincture & Sublingual’s 58.29% MoM growth at a $25.72 average price signals a mid-priced lane for recovery. In Michigan and within Edible, the absent rank reading combined with -42.13% YoY and -16.11% MoM suggests positioning risk in the core category, implying Zilla's should lean into Tincture & Sublingual’s MoM traction while stabilizing Edible price-pack architecture to reduce reliance on Topical’s YoY surge.
Competitive Landscape
Zilla's ranks #112 in MI Edible in September 2026, down 4 positions year over year from #108, and 13 positions below its June 2026 level of #99, while still trailing its April 2025 peak of #86; by contrast, Wyld held #1 both year over year and in September 2026 despite a -18.3% YoY sales change, and Rocket (MI) advanced from #14 to #5 alongside a 65.2% YoY sales increase, indicating Zilla's relative position is slipping against both stable leaders and fast risers. This pattern implies the brand's rank trajectory is drifting downward as peers consolidate share at the top and momentum players capture mid-tier gains, raising the bar for re-entry into the top 100.
Notable Products
CBD Highly Effective Relief Cream (2000mg CBD, 2oz) posted the steepest decline at -52.27% MoM while falling behind two Edible leaders that rose triple-digits, which signals a pivot away from high-dose Topicals in September 2026. CBD Assorted Gummy Butterflies (400mg CBD) jumped +141.60% MoM to rank 1, and Calm & Sleep Honey (200mg) climbed +122.55% to rank 2, while CBD/CBG Migraine Relif Stick Roll On (500mg CBD, 500mg CBG, 0.5oz) slid -12.87% at rank 3; four of the top ten are Edible SKUs, indicating concentration in ingestibles. Blueberry Honey (200mg) declined -21.84% at rank 6 as CBD/CBN 1:1 Calm & Sleep CBN Gummy Bears 20-Pack (100mg CBD, 100mg CBN) fell -39.37% at rank 6, yet the Edible tier still holds the top two ranks and captured at least $1,295 on the leading SKU, implying Zilla's is consolidating demand around lower-dose, sleep and candy-format Edibles while Topicals retreat.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
